Daniela Shveid Gerson retweeted
In a joint work between hematology and oncology we present this narrative review
Thank you
@mistralCM @taliawegman @DSG_MD @trejo_becer
Somatic Landscape of Oncogenic Variants Across the Main Cancer Subtypes in Latin America: ascopubs.org/doi/10.1200/GO-…
Daniela Shveid Gerson retweeted
In ongoing care, clinical documentation, the most important part is to be told what the author is thinking. what is available elsewhere or the historic aspect is of much lower relevance.
Daniela Shveid Gerson retweeted
Awareness, Knowledge & Treatment Patterns of Non-Metastatic Inflammatory #breastcancer in Low & Middle-Income Countries: The BRIDGES Study ➡️ brnw.ch/21wQ1tr
Co-authors: @stolaney1 @curijoey @jenniferbellon2 @DSG_MD @inas_md @SarahSewar @jamecancerdoc @DFCI_BreastOnc
Daniela Shveid Gerson retweeted
ascopubs.org/doi/10.1200/GO-…
Grateful for amazing global 🌎collaborators that made this possible: @darioT_ @FilipaLynce @stolaney1 @curijoey @DSG_MD @inas_md @SarahSewar @jamecancerdoc @EnriqueSoto8 @Otto_DFCI @DFCI_BreastOnc @IBC_DanaFarber @OncoAlert
Daniela Shveid Gerson retweeted
The BRIDGES study is now @JCOGO_ASCO
❓ Management of IBC in low and middle income countries
✅ 112 responses from clinicians from 36 counties
🔑 1/3 of patients with non metastatic IBC are receiving TMT
🔑 provider education everywhere is key to improve patient outcomes
Daniela Shveid Gerson retweeted
Thank you @DSG_MD for inviting me to give grand rounds at the Centro Médico ABC in Mexico City ⭐️
Daniela Shveid Gerson retweeted
Updated (non-exhaustive) breast cancer treatment algorithms, now including adjuvant ribociclib and other recent updates.
I am happy to be running out of space as treatment options continue to expand!
@OncoAlert #bcsm
Daniela Shveid Gerson retweeted
Mucha participación en el Seminario OMI-MEX CHOP de Liderazgo Médico 2024
#seminario #seminarios #medicina #medicos #médico #médicos #salud #health
Daniela Shveid Gerson retweeted
Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in @NatureComms. nature.com/articles/s41467-0… 🧵
Daniela Shveid Gerson retweeted
Replying to @ESOncology
@ESOncology
#ESOambassador
#meeting #workingGroup
@DSG_MD @Gordana5kovska @JoanaMarinhOnc @AnnaVasileva @anjakova
@fedrophd – at Milan, Lombardy
Daniela Shveid Gerson retweeted
10 days to Xmas🎄....and less than 4 weeks to #GI24 @ASCO 🙌
Here are the key #GI #abstracts I am waiting for👇
Special Mentions
🌟NETTER2 - Dr. Simron Singh🇨🇦 #NET
🌟COBRA (NRG GI-005) - @VanMorrisMD
@CDNCancerTrials @howiel2013 #CRCsm #ctDNA
Congrats to #GI24 planning committee for an exciting program @rachnatshroff & congrats to presenters👏
➡️abstract release date Jan 16th
Best Wishes for the Holiday Season ❄️ and look forward to seeing many of you in @SanFrancisco🤗
@OncoAlert #MedTwitter @oncodaily @OncEd
Daniela Shveid Gerson retweeted
Happy Holidays!!! from our @ABCcentromedico Oncology Family 🦀 🇲🇽 🎄 – at Álvaro Obregón, Distrito Federal
Daniela Shveid Gerson retweeted
2023 was an outstanding year for breast cancer research
As we start wrapping up #SABCS23, we need to think about how to incorporate what we learned in the clinic and future research.
Looking forward to what is yet to come to improve outcomes for our patients!
@OncoAlert #BCSM
Daniela Shveid Gerson retweeted
Great international collaboration!! 🇧🇷🇲🇽🇮🇹🇪🇸🌍Great to see Mexican representation @INCMNSZ_Uronco – at Tlalpan, Distrito Federal
Just out! SII index as a prognostic tool for mRCC in the immune combos era. Thanks all ARON team for the support. @fmassari79 @drenriquegrande @BourlonMaite @DrAndreFay @CPRT65 @JaviMolinaC
clinical-genitourinary-cance…
Daniela Shveid Gerson retweeted
Así se vivió el curso corto de actualización de genética y genómica para el oncólogo. ¡Agradecemos a todos los asistentes!
.
.
#smeo #sociedadmexicanadeoncología #médicosoncólogos #genéticaygenómica #oncology #oncología #cursocorto
Daniela Shveid Gerson retweeted
Day 1 #ESMO23 Highlights #CommunityOncology
NSCLS
1. #CM816 @DrMarkAwad
2. #KN671 @DoctorJSpicer
3. #ATTLAS
Breast Ca
4. #MonarchE #bcsm
5. #KN756/#CM7FL @LoiSher
6. #KN522 TNBC @JavierCortesMD
#lcsm #OncTwitter @myESMO #OncEd @OncoAlert @DrSGraff @g_mountzios
1/7
Daniela Shveid Gerson retweeted
#ESMO23 Day2 ⚡️🔥 #CommunityOncology
1. DB04 ⬇️Her2 #bcsm
#NSCLC
2. #ALINA ALK+ @bensolomon1
3. #LIBRETTO431 RET+
4. #PAPILLON Exon20
5. #CM77T ✂️
6. #LITESPARK005 Belzutifan-RCC @DrChoueiri
7. #SPOTLIGHT Cldn18.2 #gism
#OncTwitter #MedTwitter @myESMO #lcsm
1/8
Daniela Shveid Gerson retweeted
Past/present: ADAURA in EGFR+
Present/Future: ALINA in ALK+
Future: LIBRETTO-432 in RET+ NSCLC?
Several clinical Qx
ADJ TKI if minimal residual disease? Or for those w/oMRD?
Improving worldwide inequalities
@EGFRResisters @ALKPositiveinc @RETpositive @EGFRmNSCLC
@OncoAlert














































